Fortive price target raised to $58 from $55 at Truist

Truist raised the firm’s price target on Fortive (FTV) to $58 from $55 and keeps a Hold rating on the shares. Demand in North America for sterilization and biomedical equipment improved sequentially, while AHS – Advanced Healthcare Solution – adjusted EBITDA was 28.1%, reflecting gross profit growth and lower costs, the analyst tells investors in a research note.